Bronchoscopic local instillation of amphotericin B deoxycholate as adjunctive therapy for pulmonary mucormycosis with inadequate response to posaconazole: a retrospective case series - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Endobronchial Administration of Amphotericin B Deoxycholate as an Adjunctive Treatment for Pulmonary Mucormycosis Unresponsive to Posaconazole: A Retrospective Case Review

  • By

  • Liyan Qiu

  • Binyue Liang

  • Hua Zhou

  • August 17, 2026

Share

Original Source(s)

Bronchoscopic local instillation of amphotericin B deoxycholate as adjunctive therapy for pulmonary mucormycosis with inadequate response to posaconazole: a retrospective case series

  • by Liyan Qiu, Binyue Liang, Hua Zhou

  • August 17, 2026

Related Content

Correction: IDEIS: a tool to identify PTPRC/CD45 isoforms from single-cell transcriptomic data

FDA Monthly Preview: Key August Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Converging evidence for a two-domain framework of microvascular dysfunction in sepsis